Project 3 – Dr. Jefferson Kinney
<h3>The Role of GABA in Microglial Activation and Neurodegeneration in Alzheimer's Disease</h3>

Jefferson W. Kinney, Ph.D.
<iframe width="1280" height="720" src="https://www.youtube.com/embed/H1GWCxz0FLs?rel=0" frameborder="0" gesture="media" allow="encrypted-media" allowfullscreen></iframe>
Specific Aims:
- Examination of GABA and immune alterations in a mouse model of AD.
- Cross CX3CR1-CRE-ER mice with GABAB(1)lox511/lox511 mice to allow an inducible knockout of GABAB receptors specific to microglia.
- Determine if removal of GABABR on microglia exacerbate behavioral or pathological markers of AD in each of the groups tested in SA2 (WT, 3xTg-AD, GABABR microglial KO, 3xTg-AD + GABABR microglial KO).
Personnel:
- Dr. Arnold Salazar
- Andrew Murtishaw
- Austin Boren
- Amanda Leisigang
Internal Mentor

Martin Schiller, Ph.D.
Professor at UNLV
Director, Nevada Institute for Personalized Medicine
(Mentor: Project 3)